Accumulation and time to steady state for drugs subject to enterohepatic cycling: a stimulation study. 1985

T A Shepard, and D J Gannaway, and G F Lockwood

A physiologically realistic model was used to investigate through simulation the multiple-dose behavior of drugs subject to enterohepatic cycling. The model included separate liver and gallbladder compartments and instantaneous emptying of the gallbladder at regular intervals of length phi. Two half-lives are described, only one of which is predictive of time to steady state and accumulation. This predictive half-life would be obtained if plasma samples were taken at regular intervals equal to phi, and has been termed the effective half-life. Incorporation of gallbladder emptying at irregular intervals into the model did not materially alter our conclusions regarding the existence and predictive nature of the effective half-life.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D004364 Pharmaceutical Preparations Drugs intended for human or veterinary use, presented in their finished dosage form. Included here are materials used in the preparation and/or formulation of the finished dosage form. Drug,Drugs,Pharmaceutical,Pharmaceutical Preparation,Pharmaceutical Product,Pharmaceutic Preparations,Pharmaceutical Products,Pharmaceuticals,Preparations, Pharmaceutical,Preparation, Pharmaceutical,Preparations, Pharmaceutic,Product, Pharmaceutical,Products, Pharmaceutical
D004764 Enterohepatic Circulation Recycling through liver by excretion in bile, reabsorption from intestines (INTESTINAL REABSORPTION) into portal circulation, passage back into liver, and re-excretion in bile. Circulation, Enterohepatic,Entero-Hepatic Circulation,Circulation, Entero-Hepatic,Circulations, Entero-Hepatic,Circulations, Enterohepatic,Entero Hepatic Circulation,Entero-Hepatic Circulations,Enterohepatic Circulations
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

T A Shepard, and D J Gannaway, and G F Lockwood
June 1989, Journal of pharmacokinetics and biopharmaceutics,
T A Shepard, and D J Gannaway, and G F Lockwood
December 1985, Journal of pharmacokinetics and biopharmaceutics,
T A Shepard, and D J Gannaway, and G F Lockwood
February 1985, Journal of pharmaceutical sciences,
T A Shepard, and D J Gannaway, and G F Lockwood
March 1982, Journal of pharmaceutical sciences,
T A Shepard, and D J Gannaway, and G F Lockwood
June 1979, Journal of pharmaceutical sciences,
T A Shepard, and D J Gannaway, and G F Lockwood
May 1999, Biopharmaceutics & drug disposition,
T A Shepard, and D J Gannaway, and G F Lockwood
July 1986, Experimental and clinical endocrinology,
T A Shepard, and D J Gannaway, and G F Lockwood
December 2000, Pharmaceutical research,
T A Shepard, and D J Gannaway, and G F Lockwood
June 1978, Journal of pharmacokinetics and biopharmaceutics,
T A Shepard, and D J Gannaway, and G F Lockwood
February 2000, Toxicology and applied pharmacology,
Copied contents to your clipboard!